The store will not work correctly when cookies are disabled.
Ethyl 3-hydroxy-1-methyl-5-(phenoxymethyl)-1H-pyrazole-4-carboxylate
ID: ALA4440085
PubChem CID: 155514549
Max Phase: Preclinical
Molecular Formula: C14H16N2O4
Molecular Weight: 276.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1c(O)nn(C)c1COc1ccccc1
Standard InChI: InChI=1S/C14H16N2O4/c1-3-19-14(18)12-11(16(2)15-13(12)17)9-20-10-7-5-4-6-8-10/h4-8H,3,9H2,1-2H3,(H,15,17)
Standard InChI Key: RQENMQYFVZAYEG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
17.5291 -17.4462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1921 -16.9683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9377 -16.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1205 -16.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8662 -16.9683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6439 -15.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6408 -14.9590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5291 -18.2634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6405 -15.5262 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3531 -16.1821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8945 -17.3756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8929 -18.1928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5998 -18.6028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5959 -19.4197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3020 -19.8296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0114 -19.4223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0104 -18.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3037 -18.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0593 -15.7709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7686 -16.1768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
1 8 1 0
4 9 1 0
6 10 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
10 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.29 | Molecular Weight (Monoisotopic): 276.1110 | AlogP: 1.88 | #Rotatable Bonds: 5 |
Polar Surface Area: 73.58 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.79 | CX Basic pKa: ┄ | CX LogP: 3.19 | CX LogD: 2.52 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.84 | Np Likeness Score: -0.90 |
References
1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML.. (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies., 163 [PMID:30529545] [10.1016/j.ejmech.2018.11.044] |